ITMI942097A0 - Antagonista della interleuchina-1 - Google Patents

Antagonista della interleuchina-1

Info

Publication number
ITMI942097A0
ITMI942097A0 ITMI942097A ITMI942097A ITMI942097A0 IT MI942097 A0 ITMI942097 A0 IT MI942097A0 IT MI942097 A ITMI942097 A IT MI942097A IT MI942097 A ITMI942097 A IT MI942097A IT MI942097 A0 ITMI942097 A0 IT MI942097A0
Authority
IT
Italy
Prior art keywords
interleukin
antagonist
Prior art date
Application number
ITMI942097A
Other languages
English (en)
Inventor
Francesco Colotta
Maria Muzio
Alberto Mantovani
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of ITMI942097A0 publication Critical patent/ITMI942097A0/it
Priority to ITMI942097A priority Critical patent/IT1270662B/it
Priority to US08/476,860 priority patent/US5739282A/en
Priority to AT95936482T priority patent/ATE303439T1/de
Priority to RU97107461/13A priority patent/RU2193064C2/ru
Priority to CNB200510053993XA priority patent/CN100363053C/zh
Priority to CNB951956647A priority patent/CN1224707C/zh
Priority to PT95936482T priority patent/PT786002E/pt
Priority to ES95936482T priority patent/ES2243942T3/es
Priority to EE9700090A priority patent/EE03697B1/xx
Priority to DK95936482T priority patent/DK0786002T3/da
Priority to JP8512932A priority patent/JPH10509306A/ja
Priority to PCT/EP1995/004023 priority patent/WO1996012022A1/en
Priority to CA002202470A priority patent/CA2202470C/en
Priority to MX9702616A priority patent/MX9702616A/es
Priority to KR1019970701931A priority patent/KR100237936B1/ko
Priority to EP95936482A priority patent/EP0786002B1/en
Priority to DE69534419T priority patent/DE69534419T2/de
Priority to AU38417/95A priority patent/AU701471C/en
Priority to HK98101565.6A priority patent/HK1002659B/xx
Priority to BR9509317A priority patent/BR9509317A/pt
Priority to UA97052129A priority patent/UA65522C2/uk
Publication of ITMI942097A1 publication Critical patent/ITMI942097A1/it
Priority to NO19971624A priority patent/NO320494B1/no
Application granted granted Critical
Publication of IT1270662B publication Critical patent/IT1270662B/it
Priority to US08/910,884 priority patent/US5981713A/en
Priority to US08/910,733 priority patent/US5837495A/en
Priority to HK06103612.6A priority patent/HK1081124B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
ITMI942097A 1994-10-13 1994-10-13 Antagonista della interleuchina-1 IT1270662B (it)

Priority Applications (25)

Application Number Priority Date Filing Date Title
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1
US08/476,860 US5739282A (en) 1994-10-13 1995-06-07 Interleukin-1 antagonist
CA002202470A CA2202470C (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1-receptor antagonist
EP95936482A EP0786002B1 (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist
CNB200510053993XA CN100363053C (zh) 1994-10-13 1995-10-12 白细胞介素-1受体拮抗剂的细胞内同种型
CNB951956647A CN1224707C (zh) 1994-10-13 1995-10-12 白细胞介素－1受体拮抗剂的细胞内同种型
PT95936482T PT786002E (pt) 1994-10-13 1995-10-12 Isoforma intracelular do antagonista do receptor da interleuquina-1
ES95936482T ES2243942T3 (es) 1994-10-13 1995-10-12 Isoforma intracelular del antagonista del receptor de la interleuquina.
EE9700090A EE03697B1 (et) 1994-10-13 1995-10-12 Interleukiin-1 retseptori antagonisti intratsellulaarne isovorm
DK95936482T DK0786002T3 (da) 1994-10-13 1995-10-12 Intracellulær isoform af interleukin-1-receptorantagonisten
JP8512932A JPH10509306A (ja) 1994-10-13 1995-10-12 インターロイキン−１レセプターアンタゴニストの細胞内イソ形態
PCT/EP1995/004023 WO1996012022A1 (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist
AT95936482T ATE303439T1 (de) 1994-10-13 1995-10-12 Intrazelluläre isoform von interleukin-1 rezeptor antagonist
MX9702616A MX9702616A (es) 1994-10-13 1995-10-12 Isoforma intracelular del antagonista receptor de interleucina -1.
KR1019970701931A KR100237936B1 (ko) 1994-10-13 1995-10-12 인터루킨-1 길항제
RU97107461/13A RU2193064C2 (ru) 1994-10-13 1995-10-12 Внутриклеточная изоформа антагониста рецептора интерлейкина-1
DE69534419T DE69534419T2 (de) 1994-10-13 1995-10-12 Intrazelluläre isoform von interleukin-1 rezeptor antagonist
AU38417/95A AU701471C (en) 1994-10-13 1995-10-12 Interleukin-1 antagonist
HK98101565.6A HK1002659B (en) 1994-10-13 1995-10-12 Intracellular isoform of the interleukin-1 receptor antagonist
BR9509317A BR9509317A (pt) 1994-10-13 1995-10-12 Antagonista a interleucina-1
UA97052129A UA65522C2 (en) 1994-10-13 1995-12-10 Inner cellular isoform of interleukin-1 receptor antagonist
NO19971624A NO320494B1 (no) 1994-10-13 1997-04-09 Renset protein med antagonistisk aktivitet mot minst en av forbindelsene valgt fra gruppen bestaende av interleukin-1-a og interleikun-1-b, isolert DNA sekvens, vektor, vertscelle, og fremgangsmater og anvendelser derav.
US08/910,884 US5981713A (en) 1994-10-13 1997-08-13 Antibodies to intereleukin-1 antagonists
US08/910,733 US5837495A (en) 1994-10-13 1997-08-13 DNA encoding interleukin-1 antagonist
HK06103612.6A HK1081124B (en) 1994-10-13 2006-03-22 Intracellular isoform of the interleukin-1 receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1

Publications (3)

Publication Number Publication Date
ITMI942097A0 true ITMI942097A0 (it) 1994-10-13
ITMI942097A1 ITMI942097A1 (it) 1996-04-13
IT1270662B IT1270662B (it) 1997-05-07

Family

ID=11369705

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI942097A IT1270662B (it) 1994-10-13 1994-10-13 Antagonista della interleuchina-1

Country Status (18)

Country Link
US (1) US5739282A (it)
EP (1) EP0786002B1 (it)
JP (1) JPH10509306A (it)
KR (1) KR100237936B1 (it)
CN (2) CN1224707C (it)
AT (1) ATE303439T1 (it)
BR (1) BR9509317A (it)
CA (1) CA2202470C (it)
DE (1) DE69534419T2 (it)
EE (1) EE03697B1 (it)
ES (1) ES2243942T3 (it)
IT (1) IT1270662B (it)
MX (1) MX9702616A (it)
NO (1) NO320494B1 (it)
PT (1) PT786002E (it)
RU (1) RU2193064C2 (it)
UA (1) UA65522C2 (it)
WO (1) WO1996012022A1 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075222A (en) * 1988-05-27 1991-12-24 Synergen, Inc. Interleukin-1 inhibitors
US5872095A (en) * 1990-05-01 1999-02-16 Chiron Corporation IL-1 receptor antagonists medicaments
EA001866B1 (ru) * 1996-10-31 2001-10-22 Апплайд Резеч Системз Арс Холдинг Н.В. ПЕПТИД, СПОСОБНЫЙ СВЯЗЫВАТЬСЯ С ИНТЕРЛЕЙКИН-1-beta-КОНВЕРТИРУЮЩИМ ФЕРМЕНТОМ (ICE), И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ НА ЕГО ОСНОВЕ
CA2273852C (en) * 1996-12-06 2009-09-29 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
US6294170B1 (en) 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
IL126562A0 (en) * 1998-10-14 1999-08-17 Interpharm Lab Ltd Expression and secretion of icil-1 receptor antagonist type ii
US20020077276A1 (en) * 1999-04-27 2002-06-20 Fredeking Terry M. Compositions and methods for treating hemorrhagic virus infections and other disorders
US7166712B2 (en) * 2000-07-12 2007-01-23 Philadelphia, Health And Education Corporation Mammalian MDM2 binding proteins and uses thereof
JP4943161B2 (ja) * 2003-12-23 2012-05-30 ジェネンテック， インコーポレイテッド 新規抗ｉｌ１３モノクローナル抗体での癌の処置
ES2706848T3 (es) 2004-07-06 2019-04-01 Zymogenetics Inc Composición farmacéutica que comprende FGF18 y antagonista de IL-1 y método de uso
RU2326947C2 (ru) * 2004-11-23 2008-06-20 Общество с ограниченной ответственностью "ЦИТОКИН" Способ получения рекомбинантного антагониста рецептора интерлейкина-1 человека "арил"
CN101374864A (zh) * 2006-01-31 2009-02-25 诺瓦提斯公司 用于靶向癌症的il-17拮抗性抗体
EP2217258B1 (en) 2007-11-14 2014-03-26 General Regeneratives Limited Use of interleukin-1 receptor antagonist as a myeloprotective agent
CN101690801B (zh) 2009-10-26 2012-08-01 上海交通大学 白细胞介素-1受体拮抗剂的用途及其药物组合物
WO2012122985A1 (en) 2011-03-14 2012-09-20 University Of Copenhagen Antagonists of the interleukin- 1 receptor
DK2859015T3 (en) 2012-06-08 2018-06-18 Alkermes Inc LIGANDS MODIFIED BY CIRCULAR MODIFICATION AS AGONISTS AND ANTAGONISTS
WO2015191783A2 (en) 2014-06-10 2015-12-17 Abbvie Inc. Biomarkers for inflammatory disease and methods of using same
EA202191354A1 (ru) * 2018-11-15 2021-08-11 Янссен Байотек, Инк. Способы и композиции для прогнозирования ответа на терапию воспалительного заболевания кишечника

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148009B1 (ko) * 1988-05-27 1998-08-01 그래고리 비. 아보트 인터루킨-1 억제제
HUT64582A (en) * 1989-11-29 1994-01-28 Synergen Inc Method for producing recombinant human interleukin-1 inhibitor
AU649245B2 (en) * 1990-04-02 1994-05-19 Amgen, Inc. Methods for treating interleukin-1 mediated diseases
AU7683391A (en) * 1990-04-27 1991-11-27 Upjohn Company, The Modified interleukin-1 inhibitors
EP0534978B1 (en) * 1990-05-01 1999-03-24 Chiron Corporation Interleukin-1 antagonist and uses thereof

Also Published As

Publication number Publication date
KR970706391A (ko) 1997-11-03
NO971624D0 (no) 1997-04-09
EE9700090A (et) 1997-10-15
CN1224707C (zh) 2005-10-26
HK1002659A1 (en) 1998-09-11
CA2202470C (en) 2008-09-16
CN1161058A (zh) 1997-10-01
US5739282A (en) 1998-04-14
AU3841795A (en) 1996-05-06
KR100237936B1 (ko) 2000-01-15
UA65522C2 (en) 2004-04-15
NO320494B1 (no) 2005-12-12
DE69534419T2 (de) 2006-06-14
IT1270662B (it) 1997-05-07
ES2243942T3 (es) 2005-12-01
EP0786002B1 (en) 2005-08-31
ATE303439T1 (de) 2005-09-15
AU701471B2 (en) 1999-01-28
JPH10509306A (ja) 1998-09-14
CA2202470A1 (en) 1996-04-25
RU2193064C2 (ru) 2002-11-20
MX9702616A (es) 1998-04-30
ITMI942097A1 (it) 1996-04-13
PT786002E (pt) 2005-11-30
WO1996012022A1 (en) 1996-04-25
NO971624L (no) 1997-05-30
CN1679919A (zh) 2005-10-12
BR9509317A (pt) 1997-10-14
CN100363053C (zh) 2008-01-23
HK1081124A1 (zh) 2006-05-12
EE03697B1 (et) 2002-04-15
DE69534419D1 (de) 2005-10-06
EP0786002A1 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
FI972194A7 (fi) Uusia bentsyylipyrimidiinejä
BR9502236A (pt) Dispositivo elétrico
FI955291A0 (fi) Haittarakenne
FI953710L (fi) Uusia pyrrolokarbatsoleja
FI960734L (fi) Liitosrakenne
DE69728231D1 (de) Firststruktur
KR950029331U (ko) 침대 겸용 소파
DE59800595D1 (de) Verstellbarer anschlag
FI970528A7 (fi) Kaarisaha
KR950025210U (ko) 건축용 연결부재 구조
KR950027351U (ko) 반목 항타장치
KR960016562U (ko) 전극고정치구
KR960009130U (ko) 단자 고정대
KR960012685U (ko) 씨모오스 구조
KR960006219U (ko) 측정대구조
KR960011162U (ko) 단열재 고정기구
KR960011163U (ko) 단열재 고정기구
ITUD960033V0 (it) Struttura antisfalcio
ITUD960189A3 (it) Struttura antisfalcio
NO962890D0 (no) Brokonstruksjon
KR960003817U (ko) 가구조립용 블록
FI943495A7 (fi) Pielirakenne
KR960005207U (ko) 제승기
FI1447U1 (fi) Provtagare
KR970050229U (ko) 국기봉 고정구

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030